Verona Pharma plc — Form D
Verona Pharma plc of London, X0, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-30. The offering totals $200.2M, of which $200.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-07-30
- Form: D
- Accession: 0001567619-20-013888
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $200.2M
- Amount sold: $200.2M
- Investors: 43
- Date of first sale: 2020-07-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-372077
Issuer
- Name: Verona Pharma plc
- CIK: 0001657312
- Entity type: Corporation
- Jurisdiction: UNITED KINGDOM
- Address: 3 More London Riverside, London, X0, SE1 2RE
- Phone: 011-44-0-2032834200
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Ken W Cunningham | Director | London, X0 |
| David W Ebsworth | Director | London, X0 |
| Martin W Edwards | Director | London, X0 |
| Rishi W Gupta | Director | London, X0 |
| Mahendra W Shah | Director | London, X0 |
| Andrew W Sinclair | Director | London, X0 |
| Vikas W Sinha | Director | London, X0 |
| Anders W Ullman | Director | London, X0 |
| David Zaccardelli | Director | Research Triangle Park, NC |
| Mark W Hahn | Executive Officer | London, X0 |
| Claire W Poll | Executive Officer | London, X0 |
| Kathleen W Rickard | Executive Officer | London, X0 |
| David Zaccardelli | Executive Officer | Research Triangle Park, NC |
| Ken Cunningham | Director | Chicago, IL |
| Jan-Anders Karlsson | Director | New York, NY |
| Jan-Anders Karlsson | Executive Officer | New York, NY |
| Kenneth Newman | Executive Officer | Loveland, CO |
| David Ebsworth | Director | LONDON, X0 |
| Patrick Humphrey | Director | LONDON, X0 |
| Peter Spargo | Executive Officer | LONDON, X0 |
| Anders Ullman | Director | LONDON, X0 |
Other filings by this issuer (1)
More